Spirax Group PLC
SPX: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|qT | LOCK|?K | LOCK|>BCrK$ |
Spirax Earnings: On Track to Reach Medium-Term EBIT Margin Following Recovery; Shares Cheap
Spirax reported 4% organic revenue growth during fiscal 2024, comfortably above global industrial production and broadly in line with company-compiled consensus. Shares are trading 2% lower intraday.
